Miller Anestesia

338. Shibutani K, Inchiosa MA Jr, Sawada K, Bairamian

M: Pharmacokinetic mass of fentanyl for postope-

rative analgesia in lean and obese patients. Br J

Anaesth 95:377–383, 2005.

339. Glass PS, Doherty M, Jacobs JR, et al: Plasma con-

centration of fentanyl, with 70% nitrous oxide, to

prevent movement at skin incision. Anesthesiology

78:842–847, 1993.

340. Han T, Kim D, Kil H, Inagaki Y: The effects of

plasma fentanyl concentrations on propofol requi-

rement, emergence from anesthesia, and postopera-

tive analgesia in propofol–nitrous oxide anesthesia.

Anesth Analg 90:1365–1371, 2000.

341. Vuyk J, Lim T, Engbers FH, et al: Pharmacodyna-

mics of alfentanil as a supplement to propofol or

nitrous oxide for lower abdominal surgery in female

patients. Anesthesiology 78:1036–1045, discussion

1023A, 1993.

342. Mertens MJ, Vuyk J, Olofsen E, et al: Propofol alters

the pharmacokinetics of alfentanil in healthy male

volunteers. Anesthesiology 94:949–957, 2001.

343. Glass PS, Doherty M, Jacobs JR, et al: CP

for sufen-

tanil. Anesthesiology 73:A378, 1990.

344. Thomson IR, Henderson BT, Singh K, Hudson RJ:

Concentration-response relationships for fentanyl

and sufentanil in patients undergoing coronary

artery bypass grafting. Anesthesiology 89:852–861,

1998.

345. Patel SS, Spencer CM: Remifentanil. Drugs 52:

417–427, 1996.

346. Hogue CW Jr, Bowdle TA, O’Leary C, et al: A mul-

ticenter evaluation of total intravenous anesthesia

with remifentanil and propofol for elective inpatient

surgery. Anesth Analg 83:279–285, 1996.

347. Avramov MN, Smith I, White PF: Interactions

between midazolam and remifentanil during moni-

tored anesthesia care.Anesthesiology 85:1283–1289,

1996.

348. Sneyd JR, Whaley A, Dimpel HL, Andrews CJ: An

open, randomized comparison of alfentanil, remi-

fentanil and alfentanil followed by remifentanil in

anaesthesia for craniotomy.Br JAnaesth 81:361–364,

1998.

349. Fletcher D, Pinaud M, Scherpereel P, et al: The effi-

cacy of intravenous 0.15 versus 0.25mg/kg intraope-

rative morphine for immediate postoperative

analgesia after remifentanil-based anesthesia for

major surgery. Anesth Analg 90:666–671, 2000.

350. Kochs E, Cote D, Deruyck L, et al: Postoperative

pain management and recovery after remifentanil-

based anaesthesia with isoflurane or propofol for

major abdominal surgery. Remifentanil Study

Group. Br J Anaesth 84:169–173, 2000.

351. Guignard B, Coste C, Costes H, et al: Supplemen-

ting desflurane-remifentanil anesthesia with small-

dose ketamine reduces perioperative opioid

analgesic requirements. Anesth Analg 95:103–108,

2002.

352. Eltzschig HK, Schroeder TH, Eissler BJ, et al: The

effect of remifentanil or fentanyl on postoperative

vomiting and pain in children undergoing stra-

bismus surgery. Anesth Analg 94:1173–1177,

2002.

353. Calderon E, Pernia A, De Antonio P, et al: A compa-

rison of two constant-dose continuous infusions of

remifentanil for severe postoperative pain. Anesth

Analg 92:715–719, 2001.

354. Vinik HR, Bradley EL Jr, Kissin I: Triple anesthetic

mbination:Propofol-midazolam-alfentanil.Anesth

Analg 78:354–358, 1994.

355. Vuyk J, Lim T, Engbers FH, et al: The pharmacody-

namic interaction of propofol and alfentanil during

lower abdominal surgery in women.Anesthesiology

83:8–22, 1995.

356. Stanski DR, Shafer SL: Quantifying anesthetic drug

interaction. Implications for drug dosing. Anesthe-

siology 83:1–5, 1995.

357. Richards MJ, Skues MA, Jarvis AP, Prys Roberts C:

Total i.v. anaesthesia with propofol and alfentanil:

Dose requirements for propofol and the effect of pre-

medication with clonidine. Br J Anaesth 65:157–163,

1990.

358. Wuesten R, Van Aken H, Glass PS, Buerkle H:

Assessment of depth of anesthesia and postopera-

tive respiratory recovery after remifentanil- versus

alfentanil-based total intravenous anesthesia in

patients undergoing ear-nose-throat surgery. Anes-

thesiology 94:211–217, 2001.

359. Vuyk J, Hennis PJ, Burm AG, et al: Comparison of

midazolam and propofol in combination with alfen-

tanil for total intravenous anesthesia. Anesth Analg

71:645–650, 1990.

360. Bell J, Sartain J, Wilkinson GA, Sherry KM: Propo-

fol and fentanyl anaesthesia for patients with low

cardiac output state undergoing cardiac surgery:

Comparison with high-dose fentanyl anaesthesia.

Br J Anaesth 73:162–166, 1994.

361. Engoren M, Luther G, Fenn Buderer N: A compa-

rison of fentanyl, sufentanil, and remifentanil for

fast-track cardiac anesthesia. Anesth Analg 93:859–

864, 2001.

362. Howie MB, Black HA, Romanelli VA, et al: A com-

parison of isoflurane versus fentanyl as primary

anesthetics for mitral valve surgery. Anesth Analg

83:941–948, 1996.

363. Duncan HP, Cloote A, Weir PM, et al: Reducing

stress responses in the pre-bypass phase of open

heart surgery in infants and young children: A com-

parison of different fentanyl doses. Br J Anaesth

84:556–564, 2000.

364. Beilin B, Shavit Y, Hart J, et al: Effects of anesthesia

based on large versus small doses of fentanyl on

natural killer cell cytotoxicity in the perioperative

period. Anesth Analg 82:492–497, 1996.

365. Takahashi M, Sugiyama K, Hori M, et al: Naloxone

reversal of opioid anesthesia revisited: Clinical eva-

luation and plasma concentration analysis of conti-

nuous naloxone infusion after anesthesia with

high-dose fentanyl. J Anesth 18:1–8, 2004.

366. Silbert BS, Scott DA, Evered LA, et al: A comparison

of the effect of high- and low-dose fentanyl on the

incidence of postoperative cognitive dysfunction

after coronary artery bypass surgery in the elderly.

Anesthesiology 104:1137–1145, 2006.

367. Mantz J, Abi Jaoude F, Ceddaha A, et al: High-dose

alfentanil for myocardial revascularization: A

hemodynamic and pharmacokinetic study. J Car-

diothorac Vasc Anesth 5:107–110, 1991.

368. Roekaerts PM, Gerrits HJ, Timmerman BE, de

Lange S: Continuous infusions of alfentanil and

propofol for coronary artery surgery. J Cardiothorac

Vasc Anesth 9:362–367, 1995.

369. Howie MB, Smith DF, Reilley TE, et al: Postopera-

tive course after sufentanil or fentanyl anesthesia for

coronary artery surgery. J Cardiothorac Vasc Anesth

5:485–489, 1991.

370. Sareen J, Hudson RJ, Rosenbloom M, Thomson IR:

Dose-response to anaesthetic induction with sufen-

tanil: Haemodynamic and electroencephalographic

effects. Can J Anaesth 44:19–25, 1997.

371. Abrams JT, Horrow JC, Bennett JA, et al: Upper

airway closure: A primary source of difficult venti-

lation with sufentanil induction of anesthesia.

Anesth Analg 83:629–632, 1996.

372. Jain U, Body SC, Bellows W, et al: Multicenter study

of target-controlled infusion of propofol-sufentanil

or sufentanil-midazolam for coronary artery bypass

graft surgery. Multicenter Study of Perioperative

Ischemia (McSPI) Research Group. Anesthesiology

85:522–535, 1996.

373. Ahonen J, Olkkola KT, Verkkala K, et al: A compa-

rison of remifentanil and alfentanil for use with

propofol in patients undergoing minimally invasive

coronary artery bypass surgery. Anesth Analg

90:1269–1274, 2000.

374. Kazmaier S, Hanekop GG, Buhre W, et al: Myocar-

dial consequences of remifentanil in patients with

coronary artery disease. Br J Anaesth 84:578–583,

2000.

375. Geisler FE, de Lange S, Royston D, et al: Efficacy and

safety of remifentanil in coronary artery bypass

graft surgery: A randomized, double-blind dose

comparison study. J Cardiothorac Vasc Anesth

17:60–68, 2003.

376. Sandler AN, Baxter AD, Katz J, et al: A double-

blind, placebo-controlled trial of transdermal fen-

tanyl after abdominal hysterectomy. Analgesic,

respiratory, and pharmacokinetic effects. Anesthe-

siology 81:1169–1180, 1994.

377. Thompson JP, Bower S, Liddle AM, Rowbotham DJ:

Perioperative pharmacokinetics of transdermal fen-

tanyl in elderly and young adult patients. Br J

Anaesth 81:152–154, 1998.

378. Portenoy RK, Southam MA, Gupta SK, et al: Trans-

dermal fentanyl for cancer pain. Repeated dose

pharmacokinetics.

Anesthesiology

78:36–43,

1993.

379. Grond S, Radbruch L, Lehmann KA: Clinical phar-

macokinetics of transdermal opioids: Focus on

transdermal fentanyl. Clin Pharmacokinet 38:59–

89, 2000.

380. Ashburn MA, Streisand J, Zhang J, et al: The ionto-

phoresis of fentanyl citrate in humans. Anesthesio-

logy 82:1146–1153, 1995.

381. Power I: Fentanyl HCl iontophoretic transdermal

system (ITS): Clinical application of iontophoretic

technology in the management of acute postopera-

tive pain. Br J Anaesth 98:4–11, 2007.

382. Viscusi ER, Reynolds L, Chung F, et al: Patient-con-

trolled transdermal fentanyl hydrochloride vs intra-

venous morphine pump for postoperative pain: A

randomized controlled trial. JAMA 291:1333–1341,

2004.

383. Moa G, Zetterstrom H: Sublingual buprenorphine

as postoperative analgesic: A double-blind compa-

rison with pethidine. Acta Anaesthesiol Scand

34:68–71, 1990.

384. Manara AR, Bodenham AR, Park GR: Analgesic

efficacy of perioperative buccal morphine. Br J

Anaesth 64:551–555, 1990.

385. Friesen RH, Lockhart CH: Oral transmucosal fen-

tanyl citrate for preanesthetic medication of pedia-

tric day surgery patients with andwithout droperidol

as a prophylactic anti-emetic.Anesthesiology 76:46–

51, 1992.

386. Goldstein Dresner MC, Davis PJ, Kretchman E, et

al: Double-blind comparison of oral transmucosal

fentanyl citrate with oral meperidine, diazepam,

and atropine as preanesthetic medication in chil-

dren with congenital heart disease. Anesthesiology

74:28–33, 1991.

387. Streisand JB, Varvel JR, Stanski DR, et al: Absorp-

tion and bioavailability of oral transmucosal fen-

tanyl citrate. Anesthesiology 75:223–229, 1991.

388. Egan TD, Sharma A, Ashburn MA, et al: Multiple

dose pharmacokinetics of oral transmucosal fen-

tanyl citrate in healthy volunteers. Anesthesiology

92:665–673, 2000.

389. Dsida RM, Wheeler M, Birmingham PK, et al: Pre-

medication of pediatric tonsillectomy patients with

oral transmucosal fentanyl citrate. Anesth Analg

86:66–70, 1998.

Opioides

587

Sección

Farmacología y anestesia